Selected Scientific Publications and Posters

ORNcS Publications:

A Cross-Disciplinary Training Program for the Advancement of Medical Countermeasures
Eitzen MM, Jones EZ, McCowan J, Beasley DW
Health Security 2019 Aug 19

A Thermodynamic Mechanism for the Evasion to Antibody Neutralization in Flaviviruses
Maillard RA, Liu T, Beasley DW, Barrett AD, Hilser VJ, Lee JC
J Am Chem Soc. 2014 Jun 20

Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection
Massey S, Yeager LA, Blumentritt CA, Vijayakumar S, Sbrana E, Peterson JW, Brasel T, LeDuc JW, Endsley JJ, Torres AG.
Sci Rep. 2014 Mar 7;4:4305

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever
Gowen BB, Juelich TL, Sefing EJ, Brasel T, Smith JK, Zhang L, Tigabu B, Hill TE, Yun T, Pietzsch C, Furuta Y, Freiberg AN.
PLoS Negl Trop Dis. 2013 Dec 26;7(12)

Animal rule for drug approval creates a jungle of confusion
Elie Dolgin
Nature Medicine 19, 118-119 (2013)

WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012
Trent DW, Minor P, Jivapaisarnpong, T, Shin J, WHO Working Group on the Quality Safety and Efficacy of Japanese Encephalitis Vaccines Live Attenuated for Human Use
Biologicals. 2013 Nov;41(6):450-7

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax
Mytle N, Hopkins RJ, Malkevich NV, Basu S, Meister GT, Sanford DC, Comer JE, Van Zandt KE, Albrahim M, Kramer WG, Howard C, Daczkowski N, Chakrabarti AC, Ionin B, Nabors GS, Skiadopoulos MH
Antimicrob Agents Chemother. 2013 Nov;57(11):5684-92

Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes
Beasley DW, Morin M, Lamb AR, Hayman E, Watts DM, Lee CK, Trent DW, Monath TP
Virus Res. 2013 Sep;176(1-2):280-4

Development of an inhalational Bacillus anthracis exposure therapeutic model in cynomolgus macaques
Henning LN, Comer JE, Stark GV, Ray BD, Tordoff KP, Knostman KA, Meister GT
Clin Vaccine Immunol. 2012 Nov;19(11):1765-75

Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit model
Barnewall RE, Comer JE, Miller BD, Gutting BW, Wolfe DN, Director-Myska AE, Nichols TL, Taft SC
Front Cell Infect Microbiol. 2012 Jun 13;2:71

Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment
Comer JE, Ray BD, Henning LN, Stark GV, Barnewall RE, Mott JM, Meister GT
Clin Vaccine Immunol. 2012 Sep;19(9):1517-25

Levofloxacin cures experimental pneumonic plague in African green monkeys
Layton RC, Mega W, McDonald JD, Brasel TL, Barr EB, Gigliotti AP, Koster F
PLoS Negl Trop Dis. 2011 Feb 8;5(2):e959

Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague
Comer JE, Sturdevant DE, Carmody AB, Virtaneva K, Gardner D, Long D, Rosenke R, Porcella SF, Hinnebusch BJ
Infect Immun. 2010 Dec;78(12):5086-98

Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)
Fellow P, Adamovicz J, Hartings J, Sherwood R, Mega W, Brasel T, Barr E, Holland L, Lin W, Rom A, Blackwelder W, Price J, Morris S, Snow D, Hart MK
Vaccine. 2010 Nov 16;28(49):7748-56


Achieving Data Quality and Integrity in Maximum Containment Laboratories Pilot Course PDF document

Quality System Integration in the BSL-4 Laboratory During Regulated Nonhuman Primate Filovirus Challenge Studies PDF document